
| Duration | Percentage |
|---|---|
| 1 week | 1.23 |
| 1 month | 5.98 |
| 6 months | 61.86 |
| 9 months | 112.47 |
| 1 year | 117.07 |
| Essentials | |
|---|---|
| Fund category | Equity - Sector Fund |
| Scheme plan | Dividend |
| Scheme type | Open Ended |
| Launch date | March 31, 1999 |
| Fund manager | Mr. Anand Radhakrishnan |
| Fund info | |
|---|---|
| AMC | Franklin Templeton Asset Management (India) Pvt. Ltd. |
| Objective | The Scheme aims to achieve long term capital appreciation through exclusively investing in Pharmaceutical/Life sciences |
| Asset (Rs crore) | 54.44 ( August 31, 2009) |
| Dividend (%) | 25.00 ( October 24, 2007) |
| Company | Percentage |
|---|---|
| Ipca Laboratorie | 9.81 |
| Cadila Healthcar | 9.41 |
| Torrent Pharmac | 9.15 |
| Dr. Reddy's Labs | 7.74 |
| Piramal Healthcare L | 6.07 |
| Apollo Hospitals | 5.74 |
| Lupin Ltd. | 5.61 |
| Biocon | 5.25 |
| Aurobindo Pharma | 5.17 |
| Cipla | 4.74 |
| Company | Percentage |
|---|---|
| Pharmaceuticals | 79.0 |
| Hospitals & Medical Services | 6.0 |
| Vanaspati | 2.0 |